InfinityQS has pledged to donate $1 million to St. Jude Children's Research Hospital to support St. Jude's groundbreaking research and lifesaving care since identifying the hospital as its sole charitable partner in 2005. Charitable gifts from companies like InfinityQS have helped St. Jude make tremendous strides in its mission to find cures and save children.
St. Jude's development of combination therapy for children with acute lymphoblastic leukemia (ALL), the most common form of childhood cancer, revolutionized leukemia therapy worldwide and increased the survival rate from 4 percent, when St. Jude opened in 1962, to 94 percent today. St. Jude's innovative research has also led to a dramatic increase in survival rates for children with many other major forms of cancer.
